缩写名/全名 |
PHARM DEV TECHNOL
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY |
||||||||||||||||
ISSN号 | 1083-7450 | ||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||
影响因子 | 2015:1.566, 2016:1.86, 2017:1.945, 2018:2.347, 2019:2.169, | ||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||
年文章数 | 136 | ||||||||||||||||
出版年份 | 1996 | ||||||||||||||||
是否OA | No | ||||||||||||||||
审稿周期(仅供参考) | 平均1.0个月 |
||||||||||||||||
录用比例 | 容易 | ||||||||||||||||
投稿链接 | https://mc.manuscriptcentral.com/LPDT | ||||||||||||||||
投稿官网 | http://informahealthcare.com/journal/phd | ||||||||||||||||
h-index | 50 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1083-7450%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Mucoadhesive buccal film containing ornidazole and dexamethasone for oral ulcers: in vitro and in vivo studies. Author: Zhang C1, Liu Y1, Li W1, Gao P2, Xiang D1, Ren X1, Liu D1. Journal: Pharm Dev Technol. 2019 Jan;24(1):118-126. doi: 10.1080/10837450.2018.1428814. Epub 2018 Jan 25. PubMed DOI |
2. | Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability. Author: Zhang S1, Liu Y1, Gan Y1, Qiu N1, Gu Y2, Zhu H1. Journal: Pharm Dev Technol. 2019 Feb;24(2):253-261. doi: 10.1080/10837450.2018.1469147. Epub 2018 Jun 13. PubMed DOI |
3. | Acoustic emission detection of crystallization in two forms: monohydrate and anhydrous citric acid. Author: Wang X1, Huang Y2,3, Michelitsch TM3. Journal: Pharm Dev Technol. 2019 Apr;24(4):419-426. doi: 10.1080/10837450.2018.1507037. PubMed DOI |
4. | Preparation and in vivo pharmacokinetics of rhGH-loaded PLGA microspheres. Author: Yu Z1, Huang L1, Wen R1, Li Y1, Zhang Q2. Journal: Pharm Dev Technol. 2019 Apr;24(4):395-401. doi: 10.1080/10837450.2018.1502316. Epub 2018 Nov 13. PubMed DOI |
5. | In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin. Author: Xie MH1, Ge M1, Peng JB1, Jiang XR1, Wang DS1, Ji LQ1, Ying Y2, Wang Z3. Journal: Pharm Dev Technol. 2019 Jun;24(5):623-629. doi: 10.1080/10837450.2018.1550788. Epub 2018 Dec 9. PubMed DOI |
6. | Silk fibroin nanoparticles for enhanced bio-macromolecule delivery to the retina. Author: Yang P1, Dong Y1, Huang D1, Zhu C2, Liu H3, Pan X1, Wu C1. Journal: Pharm Dev Technol. 2019 Jun;24(5):575-583. doi: 10.1080/10837450.2018.1545236. Epub 2019 Mar 19. PubMed DOI |
7. | Preparation and Characterization of Angiopep-2 Functionalized Ginsenoside-Rg3 Loaded Nanoparticles and the Effect on C6 Glioma Cells. Author: Su X1, Zhang D1,2, Zhang H3, Zhao K2, Hou W3. Journal: Pharm Dev Technol. 2019 Jan 2:1-37. doi: 10.1080/10837450.2018.1551901. [Epub ahead of print] PubMed DOI |
8. | Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation. Author: Wang XF1, Ren J1, He HQ1, Liang L2, Xie X3, Li ZX1, Zhao JG1, Yu JM1. Journal: Pharm Dev Technol. 2019 Jul;24(6):794-802. doi: 10.1080/10837450.2019.1599914. PubMed DOI |
9. | Preparation, Optimization and Cellular Uptake Study of Tanshinone I Nanoemulsion Modified with Lactoferrin for Brain Drug Delivery. Author: Wu Y1,2, Zhang B1,2, Kebebe D1,2,3, Guo L1,2, Guo H1,2, Li N1,2, Pi J1,2, Qi D1,2, Guo P1,2, Liu Z1,2. Journal: Pharm Dev Technol. 2019 May 20:1-26. doi: 10.1080/10837450.2019.1621897. [Epub ahead of print] PubMed DOI |
10. | MMP-2-responsive gelatin nanoparticles for synergistic tumor therapy. Author: Xu Y1, Zhang J1, Liu X1, Huo P1, Zhang Y1, Chen H1, Tian Q2, Zhang N1. Journal: Pharm Dev Technol. 2019 May 21:1-26. doi: 10.1080/10837450.2019.1621899. [Epub ahead of print] PubMed DOI |
|
|